Vaccine Improves Event-Free Survival for Leukemia Patients

Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than non-responders, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.

External Link: http://www.newswise.com/articles/view/536058/